Navigation Links
Biopharmaceutical Managed Care Strength Closely Intertwined with Marketplace Success
Date:4/19/2013

CHAPEL HILL, N.C., April 19, 2013 /PRNewswire/ -- Managed care operations in the pharmaceutical sector are rapidly growing and have emerged as essential factors for success in the U.S. healthcare marketplace. Due to this rapid growth, pharmaceutical and medical device leaders have placed an increased importance on managed care activities.

While well-planned and executed managed care activities can yield sizeable returns, leaders must adapt and constantly adjust their resource levels to suit marketplace requirements. By observing the managed care activities and resourcing of major biopharmaceutical companies in the United States, executives can assess the efficiency and effectiveness of their managed care groups.

To meet the needs of leaders trying to defend their Managed Care resources and investment levels, research and consulting firm, Best Practices, LLC, conducted a primary research study on the issue. The ensuing report, "Resource Benchmarks for U.S. Pharmaceutical Managed Care Operations," delivers insights into the most effective Managed Care operations, tactics, and activities. It also provides a recent look at staffing and resourcing levels in Managed Care groups of leading U.S. pharmaceutical and biotechnology companies.

Key study topics include:

  • Overall Staffing Levels
  • Outsourcing Levels
  • Staffing Levels Per Key Activity
  • Staffing Levels Linked to Brands Supported
  • Financial Investment for U.S. Managed Care Group and Key Activities
  • Staffing Efficiency Measures

The full report contains more than 110 benchmark metrics and critical best practices and identifies industry standards for staffing, outsourcing, budget, and efficiency metrics. Collected benchmarks focused exclusively on interviews with 12 participating executives from leading companies across the pharmaceutical, biotech and medical device industries.

For more information on this study or other recent primary research studies, contact us at 919.403.0251 or visit our website at Best Practices, LLC. Check out Best Practices' blog at www.whybenchmarking.com.

ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
2. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
3. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
4. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
5. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
6. Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at WFH 2012 World Congress
7. Inspiration Biopharmaceuticals Announces Clinical Hold of Clinical Trials Evaluating IB1001 for the Treatment and Prevention of Bleeding in Hemophilia B
8. PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies
9. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Second Quarter 2012 Financial Results
10. Biopharmaceutical Service Providers Announce Collaborative Opening of Boston, MA Office
11. The Thousand-Year Business Model for a Modern Biopharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... , July 10, 2017 The Institute for ... methods, is the recipient of a VITROCELL® inhalation exposure ... International Science Consortium. The device, which is designed to ... expose human lung cells to airborne test materials in ... use the VITROCELL® system for testing combustible tobacco products, ...
(Date:7/6/2017)... division of Diplomat Specialty Infusion Group, is celebrating a decade of empowering ... celebrate its anniversary, ThriveRx recently launched a redesigned website at thriverx.diplomat.is ... to create the best user experience for consumers and health care professionals. ... Diplomat Pharmacy ... "We,ve made several great strides throughout the past 10 years," ...
(Date:7/5/2017)... , July 5, 2017   BioLife Solutions , ... manufacturer and marketer of proprietary clinical grade cell and ... media ("BioLife"), today announced that it has reached ... holder and largest shareholder, to modify its existing credit ... to the modification, WAVI agreed to exchange its existing ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... The Margarian Law Firm has filed ... of its ginger ale for allegedly containing no ginger. Dr. Pepper produces the “Canada ... Inc., plaintiff Gegham Margaryan alleges Canada Dry Ginger Ale claims on its bottle that ...
(Date:7/21/2017)... MO (PRWEB) , ... July 21, 2017 , ... “Kids ... knowing how to tie their shoes,” says Suzanne Tucker, Founder of St. Louis-based positive ... Time-In Toolkit, which launches on Kickstarter on Monday, July 21st. , The kit ...
(Date:7/21/2017)... ... July 21, 2017 , ... The ... offer patients improved quality of life five years after injury, according to research ... Meeting in Toronto, Ontario, Canada. The study followed patients for five years following ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... of blood and bone marrow cancer that progresses rapidly without treatment. Newly diagnosed ... to reduce the chance of reoccurrence and relapse. With such a challenging ...
(Date:7/20/2017)... New York (PRWEB) , ... July 20, 2017 ... ... has developed a telemedicine platform, in which their iMedSecure™ comes included with each ... both share encrypted live images to remote participants for real-time collaboration and immediate ...
Breaking Medicine News(10 mins):